TNFSF13 and familial pancreatic carcinoma: These results showed that TWEAK but not APRIL was significantly lower expressed in tumor vs non-tumor tissue (p = 0.020 and 0.60; respectively; Figure 4A,B), being fully consistent with the results we presented regarding lower levels of TWEAK in serum of patients with pancreatic cancer (Figure 2A).